Model Number 3CX*FX15RW30C |
Device Problem
Use of Device Problem (1670)
|
Patient Problem
Death (1802)
|
Event Date 09/21/2017 |
Event Type
Death
|
Manufacturer Narrative
|
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).Results: results pending completion of evaluation.Conclusion: conclusion not yet available-evaluation in progress.
|
|
Event Description
|
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, there was no oxygenation when they were using full flow to the patient.The patient was on bypass for a few hours on/off with no issue.They had to keep increasing oxygen and air gas flow.On the last run of bypass, they were using full flow to the patient but there was no oxygenation.However, once they dropped the flow to under 1/2 flow, they were able to oxygenate normally.They stopped using bypass and went on ecmo to complete the surgery.The patient later passed away but the perfusionist has confirmed that this was not related to the reported oxygenator failure.Death; product was not changed out; procedure was completed successfully.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on october 13, 2017.Upon further investigation of the reported event, the following information is new and/or changed: (device availability - date returned to manufacturer), (date received by manufacturer), (indication that this is a follow-up report), (follow-up due to additional information), (device evaluation anticipated by manufacturer - a second follow-up will be submitted upon completion of the investigation and/or submission of new information.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted.(b)(4).Visual inspection upon receipt did not find any anomalies that could have caused a gas leak or insufficient gas transfer performance.Gas transfer performance was tested on the actual sample, during which no anomalies were found and the unit met factory specifications.A review of the device history revealed no production related anomalies.The issue is likely due to the wet lung phenomenon or plasma leak occurrence wherein water condensation occurs inside the fibers of micro porous membrane oxygenators with blood flowing exterior to the fibers.This may occur when oxygenators are used for a longer period of time.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Search Alerts/Recalls
|